Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
FACS analysis shows that Human CD40 Ligand Protein, Fc Tag, premium grade (Cat. No. CDL-H5269) can bind to 293T-CD40 cells surface CD40. The concentration of Human CD40 Ligand is 0.3 μg/mL (Routinely tested).
Loaded Human CD40, Fc Tag (Cat. No. CD0-H5253) on Protein A Biosensor, can bind Human CD40 Ligand, His,Flag Tag, premium grade (Cat. No. CDL-H52Db) with an affinity constant of 1.58 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
AdCD40L | Phase 2 Clinical | Uppsala University | Urinary Bladder Neoplasms; Melanoma | Details | |
Anti-CD40L antibody (Bristol-Myers Squibb) | Phase 2 Clinical | Immunologic Deficiency Syndromes | Details | ||
rVV-740CTA vaccine (University Hospital Basel) | rVV-740CTA | University Hospital Basel | Details | ||
Letolizumab | BMS-986004; BMS2h-572-633-CT-L2 | Phase 1 Clinical | Bristol-Myers Squibb Company | Purpura, Thrombocytopenic, Idiopathic; Graft vs Host Disease | Details |
Frexalimab | INX-021; SAR-441344 | Phase 2 Clinical | Immunext Inc | Multiple Sclerosis; Lupus Erythematosus, Systemic; Sjogren-Larsson Syndrome | Details |
Delolimogene mupadenorepvec | LOAd-703 | Phase 2 Clinical | Uppsala University, Lokon Pharma | Biliary Tract Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Melanoma | Details |
MEM-288 | MEM-288 | Phase 1 Clinical | Memgen | Solid tumours; Head and Neck Neoplasms; Carcinoma, Merkel Cell; Neoplasms; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Squamous Cell; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
Tegoprubart | AT-1501 | Phase 2 Clinical | Als Therapy Development Institute, Anelixis Therapeutics Llc | Rejection of renal transplantation; Diabetes Mellitus, Type 1; Glomerulonephritis, IGA; Amyotrophic Lateral Sclerosis | Details |
APB-A1 | APB-A1; Lu-AG22515 | Phase 1 Clinical | AprilBio Co Ltd | Neuromyelitis Optica | Details |
Dazodalibep | HZN-4920(Horizon Therapeutics); UNII-HN5US76BWF; WHO-11399; VIB-4920; MEDI-4920 | Phase 2 Clinical | Medimmune Llc, Horizon Therapeutics Plc | Rejection of renal transplantation; Sjogren's Syndrome; Arthritis, Rheumatoid; Lupus Nephritis; Rejection of organ transplantation; Sjogren-Larsson Syndrome | Details |
Dapirolizumab pegol | Anti-CD40L-Fab; Anti-CD40L-Fab-PEG; CDP-7657; CD40L - Fab; BIIB-133 | Phase 3 Clinical | Biogen Inc, Ucb | Autoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Lupus Erythematosus, Systemic; Skin and Connective Tissue Diseases | Details |
This web search service is supported by Google Inc.